News
Alexandru Schiopu awarded the Erik K. Fernström prize
Calprotect’s founder Alexandru Schiopu has been awarded the “Erik K. Fernström prize” 2021 for younger, particularly promising and successful researchers at the Medical Faculty of Lund University. Read more here: Lunds Fernströmspris för forskning som förbättrar behandling av hjärtsjukdom (Swedish)
Dr. Alexandru Schiopu receives 3 MSEK from the Bundy Academy at Lund University
Dr. Alexandru Schiopu has been awarded the big prize in cardiology of 3 000 000 SEK (approximately 300 000 EUR) by the Bundy Academy at Lund University. The funds will finance Dr. Schiopu’s research aiming to understand and modulate the role of inflammation in heart disease. Read more about the prize here (Swedish): Lund University – Bundy Academy’s […]
Dr. Alexandru Schiopu won the Grand Prize in the Future Innovation Award competition
Dr. Alexandru Schiopu, founder of CALPROTECT, won the Grand Prize in the Future Innovation Award competition held by Lund University and Sparbanken Skåne, in the “Employee” category. The prize has been awarded for Dr. Schiopu’s project aiming to develop a novel anti-inflammatory therapy for myocardial infarction patients that will be further advanced by CALPROTECT. Read […]
Calprotect’s founder receives the “Prince Daniel research grant for young promising researchers” and 6 MSEK for further development
In a ceremony held at the Royal Castle in Stockholm, CALPROTECTs founder Dr. Alexandru Schiopu has personally received the “Prince Daniel research grant for young promising researchers” from His Royal Highness Prince Daniel. The grant of 6 000 000 Swedish kronor (approximately 600 000 EUR) is financed by the Swedish Heart and Lung Foundation and will support further […]
Calprotect technology highlighted as one of the most important discoveries of 2019
The findings by the team of Dr. Alexandru Schiopu on the beneficial therapeutic effects of calprotectin blockade in myocardial infarction have been highlighted as one of the most important discoveries of 2019 in coronary artery disease. The study has been included in the yearly European Heart Journal editorial “The year in cardiology: acute coronary syndromes […]
First proof-of-concept study showing that short-term blockade of calprotectin improves heart function after myocardial infarction
The research team of Dr. Alexandru Schiopu at Lund University published the first proof-of-concept study showing that short-term blockade of calprotectin (S100A8/A9) with a small molecule therapeutic inhibits inflammation, reduces heart damage and improves heart function in mice with myocardial infarction (MI). The study has been published in the European Heart Journal, the top-ranked international […]